Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study Article

sustainable development goals

publication date

  • December 1, 2025

webpage

published in

keywords

  • 10% ALA gel
  • BF-200 ALA
  • PDT
  • RhodoLED
  • aminolevulinic acid
  • basal cell carcinoma
  • photodynamic therapy
  • randomized clinical trial
  • red light

start page

  • 1489

end page

  • 1498

volume

  • 93

issue

  • 6